MATINAS BIOPHARMA HOLDINGS, INC. Preferred Stock, Liquidation Preference, Value
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Preferred Stock, Liquidation Preference, Value of $4.22 million as of 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockLiquidationPreferenceValue · last filed 2021-05-10
- 2021-03-31: Preferred Stock, Liquidation Preference, Value $4.22M.
- 2020-12-31: Preferred Stock, Liquidation Preference, Value $4.36M.
- 2020-09-30: Preferred Stock, Liquidation Preference, Value $4.55M.
- 2020-06-30: Preferred Stock, Liquidation Preference, Value $4.55M.
| Period end | Preferred Stock, Liquidation Preference, Value |
|---|---|
| 2021-03-31 | $4.22M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $4.36M 10-K · filed 2021-03-29 |
| 2020-09-30 | $4.55M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $4.55M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.55M 10-Q · filed 2020-05-11 |
| 2017-03-31 | $7.95M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $8.00M 10-K · filed 2017-03-31 |
| 2016-09-30 | $12.39M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |